[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339125-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-339125-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","blockade-of-the-deubiquitinating-enzyme-usp48-degrades-oncogenic-hmga2-and-inhibits-colorectal-cancer-invasion-and-metastasis","Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis","","HMGA2, a key transcription factor, regulates the progression of multiple aggressive cancers. This study used mass spectrometry to find ubiquitin-specific proteases interacting with HMGA2 and identified USP48 as a deubiquitinating enzyme for HMGA2. Restoring USP48 expression increased HMGA2 protein by blocking its degradation, whereas USP48 loss promoted HMGA2 degradation, suppressing colorectal cancer invasion and metastasis. USP48 was SUMOylated at lysine 258 to strengthen HMGA2 binding, and screening small molecules identified DUB-IN-2 as a potent USP48 inhibitor that destabilizes HMGA2. Overall, USP48 and HMGA2 upregulation correlated with poor prognosis, supporting USP48 targeting for colorectal cancer therapy.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/blockade-of-the-deubiquitinating-enzyme-usp48-degrades-oncogenic-hmga2-and-inhibits-colorectal-cancer-invasion-and-metastasis/339125/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/blockade-of-the-deubiquitinating-enzyme-usp48-degrades-oncogenic-hmga2-and-inhibits-colorectal-cancer-invasion-and-metastasis/339125.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What role does HMGA2 play in this colorectal cancer study?","Question",{"text":63,"@type":64},"HMGA2 is described as a pivotal transcription factor involved in the progression of aggressive malignancies. The study focuses on how its stability is regulated to affect colorectal cancer invasion and metastasis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does USP48 affect HMGA2 stability and tumor behaviors?",{"text":68,"@type":64},"USP48 increases HMGA2 protein levels by inhibiting HMGA2 degradation. Removing USP48 promotes HMGA2 degradation, thereby suppressing colorectal cancer invasion and metastasis.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the function of SUMOylation on USP48 in relation to HMGA2?",{"text":72,"@type":64},"USP48 undergoes SUMOylation at lysine 258, which enhances its binding affinity to HMGA2 and supports the regulatory mechanism controlling HMGA2 stability.",{"name":74,"@type":61,"acceptedAnswer":75},"What is DUB-IN-2 and what outcome does it produce?",{"text":76,"@type":64},"DUB-IN-2 is identified through phenotypic screening as a highly potent pharmacological inhibitor of USP48. Inhibiting USP48 with this small molecule destabilizes HMGA2, supporting USP48 as a therapeutic target for colorectal cancer.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},339125,1790200053,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":122,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":108,"preview_page_count":33,"preview_urls":148},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Acta Pharmaceutica Sinica B 2024;14(4):1624e1643  \nChinese Pharmaceutical Association  \nInstitute of Materia Medica, Chinese Academy of Medical Sciences  \nActa Pharmaceutica Sinica B  \n[www. elsevier.com/locate/apsb](www. elsevier.com/locate/apsb)[ ](www. elsevier.com/locate/apsb)[www. sciencedirect.com](www. sciencedirect.com)  \nORIGINAL ARTICLE  \nBlockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis  \nCan Chenga,b,y, Hanhui Yaoa,b,y, Heng Lib,c,y, Jingwen Liud, Zhengyi Liue, Yang Wua,b, Liang Zhua, Hejie Hua, *, Zhengdong Fanga, *, Liang Wua,b, *  \naDepartment of General Surgery, the First Afﬁliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China  \nbAnhui Province Key Laboratory of Hepatopancreatobiliary Surgery, the First Afﬁliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China cDepartment of Comprehensive Surgery, Anhui Provincial Cancer Hospital, West District of the First Afﬁliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China  \ndAnhui Provincial Hospital Health Management Center, the First Afﬁliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China  \neDepartment of Breast Surgery, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, People’s Hospital of Henan University, Zhengzhou 450003, China  \nReceived 24 October 2023; received in revised form 14 December 2023; accepted 8 January 2024  \nKEY WORDS Colorectal cancer;  \nInvasion and metastasis;  \nPost-translational modiﬁcation; Ubiquitination;  \nSUMOylation;  \nUSP48;  \nHMGA2;  \nSpeciﬁc inhibitors  \nAbstract HMGA2, a pivotal transcription factor, functions as a versatile regulator implicated in the progression of diverse aggressive malignancies. In this study, mass spectrometry was employed to identify ubiquitin-speciﬁc proteases that potentially interact with HMGA2, and USP48 was identiﬁed as adeubiquitinating enzyme of HMGA2 . The enforced expression of USP48 signiﬁcantly increased HMGA2 protein levels by inhibiting its degradation, while the deprivation of USP48 promoted HMGA2 degradation, thereby suppressing tumor invasion and metastasis. We discovered that USP48 undergoes SUMOylation at lysine 258, which enhances its binding afﬁnity to HMGA2 . Through subsequent phenotypic screening of small molecules, we identiﬁed DUB-IN-2 as a remarkably potent pharmacological inhibitor of USP48 . Interestingly, the small-molecule inhibitor targeting USP48 induces destabilization of HMGA2 . Clinically, upregulation of USP48 or HMGA2 in cancerous tissues is indicative of poor  \n*Corresponding authors.  \nE-mail addresses: [huhejie@163.com](huhejie@163.com) (Hejie Hu), [fangzhengdong@126.com](fangzhengdong@126.com) (Zhengdong Fang), [wu8722@ustc.edu.cn](wu8722@ustc.edu.cn) (Liang Wu).  \ny These authors made equal contributions to this work.  \nPeer review under the responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.  \n[https://doi.org/10.1016/j.apsb.2024.01.006](https://doi.org/10.1016/j.apsb.2024.01.006)  \n2211-3835 ª 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nprognosis for patients with colorectal cancer (CRC) . Collectively, our study not only elucidates the regulatory mechanism of DUBs involved in HMGA2 stability and validates USP48 as a potential therapeutic target for CRC, but also identiﬁes DUB-IN-2 as a potent inhibitor of U","cbCaidmSzCM8byAG","https://ap.wps.com/l/cbCaidmSzCM8byAG","pdf",6254701,"English","# Introduction\n## Colorectal cancer background and metastasis significance\n## Ubiquitination and deubiquitinating enzymes (DUBs) in cancer biology\n## Overview of DUB families and examples in tumor progression","[{\"question\":\"What role does HMGA2 play in this colorectal cancer study?\",\"answer\":\"HMGA2 is described as a pivotal transcription factor involved in the progression of aggressive malignancies. The study focuses on how its stability is regulated to affect colorectal cancer invasion and metastasis.\"},{\"question\":\"How does USP48 affect HMGA2 stability and tumor behaviors?\",\"answer\":\"USP48 increases HMGA2 protein levels by inhibiting HMGA2 degradation. Removing USP48 promotes HMGA2 degradation, thereby suppressing colorectal cancer invasion and metastasis.\"},{\"question\":\"What is the function of SUMOylation on USP48 in relation to HMGA2?\",\"answer\":\"USP48 undergoes SUMOylation at lysine 258, which enhances its binding affinity to HMGA2 and supports the regulatory mechanism controlling HMGA2 stability.\"},{\"question\":\"What is DUB-IN-2 and what outcome does it produce?\",\"answer\":\"DUB-IN-2 is identified through phenotypic screening as a highly potent pharmacological inhibitor of USP48. Inhibiting USP48 with this small molecule destabilizes HMGA2, supporting USP48 as a therapeutic target for colorectal cancer.\"}]","Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis | PDF",1790028091,[149,153,157,161],{"page_no":22,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93ee578460e4c6630dd08d3fb7905852.webp",983,1310,{"page_no":26,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c5810c58df3c4cca84d491d1d28c142.webp",982,1309,{"page_no":30,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b391575cb3061ae501846f9c99b4494a.webp",981,1308,{"page_no":33,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c41c5b65c620eb7cc56851b9c552ec9.webp",980,1306]